8-KThe WireRoutine
Bylaw Amendment
Filed Apr 15, 2020 · 6y ago · Accession 0001193125-20-108110
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Stoke Therapeutics, Inc.
- Ticker
- STOK
- CIK
- 1623526
- Form type
- 8-K
- Filing date
- Apr 15, 2020
- Report date
- Apr 14, 2020
- Document
- d909495d8k.htm
- Size
- 21 KB